Quo vadis, biotech?: (Part 1)

被引：10

作者：

Drews, J ^{[1
]}

机构：

[1] Int Biomed Management Partners, Basel, Switzerland

来源：

DRUG DISCOVERY TODAY | 2000年 / 5卷 / 12期

关键词：

D O I：

10.1016/S1359-6446(00)01580-4

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The recent increase in the capitalization value of the biotechnology industry appears to be sustainable. The phenomenon is interpreted as an acknowledgement by the markets that this industry has become the main source of innovation for the pharmaceutical industry. In addition, biotechnology is beginning to impact on other industries. However, from a methodological and strategic point of view, the biotechnology industry is still too fragmented. Consolidation along the lines of value generation in drug research and development, however, will occur. Over the next 5 to 10 years, the biotechnology industry will remain the fastest growing industry in the health care arena.

引用

页码：547 / 553

页数：7

共 18 条

[1] The genome sequence of Drosophila melanogaster [J].

Adams, MD ;

Celniker, SE ;

Holt, RA ;

Evans, CA ;

Gocayne, JD ;

Amanatides, PG ;

Scherer, SE ;

Li, PW ;

Hoskins, RA ;

Galle, RF ;

George, RA ;

Lewis, SE ;

Richards, S ;

Ashburner, M ;

Henderson, SN ;

Sutton, GG ;

Wortman, JR ;

Yandell, MD ;

Zhang, Q ;

Chen, LX ;

Brandon, RC ;

Rogers, YHC ;

Blazej, RG ;

Champe, M ;

Pfeiffer, BD ;

Wan, KH ;

Doyle, C ;

Baxter, EG ;

Helt, G ;

Nelson, CR ;

Miklos, GLG ;

Abril, JF ;

Agbayani, A ;

An, HJ ;

Andrews-Pfannkoch, C ;

Baldwin, D ;

Ballew, RM ;

Basu, A ;

Baxendale, J ;

Bayraktaroglu, L ;

Beasley, EM ;

Beeson, KY ;

Benos, PV ;

Berman, BP ;

Bhandari, D ;

Bolshakov, S ;

Borkova, D ;

Botchan, MR ;

Bouck, J ;

Brokstein, P .

SCIENCE, 2000, 287 (5461) :2185-2195

[2]

[Anonymous], 1984, EVOLUTION GENETICS P

[3] Modelling during drug development [J].

Balant, LP ;

Gex-Fabry, M .

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) :13-26

[4]

BRAY MA, 1988, PHARM LYMPHOCYTES

[5] Population statistics of protein structures: Lessons from structural classifications [J].

Brenner, SE ;

Chothia, C ;

Hubbard, TJP .

CURRENT OPINION IN STRUCTURAL BIOLOGY, 1997, 7 (03) :369-376

[6] Structural genomics: beyond the Human Genome Project [J].

Burley, SK ;

Almo, SC ;

Bonanno, JB ;

Capel, M ;

Chance, MR ;

Gaasterland, T ;

Lin, DW ;

Sali, A ;

Studier, FW ;

Swaminathan, S .

NATURE GENETICS, 1999, 23 (02) :151-157

[7]

DREWS J, 1997, HUMAN DIS GENETIC CA, P5

[8]

Drews J., 1996, DRUG INF J, V30, P97

[9]

DREWS J, 1999, QUEST NEW MED

[10] Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness [J].

Drysdale, CM ;

McGraw, DW ;

Stack, CB ;

Stephens, JC ;

Judson, RS ;

Nandabalan, K ;

Arnold, K ;

Ruano, G ;

Liggett, SB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) :10483-10488

← 1 2 →